ArticleJournal of bone oncology2019

Specific inhibition of PI3Kδ/γ enhances the efficacy of anti-PD1 against osteosarcoma cancer.

Xinge Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.